192 related articles for article (PubMed ID: 36686473)
1. Whole-exome sequencing and bioinformatic analyses revealed differences in gene mutation profiles in papillary thyroid cancer patients with and without benign thyroid goitre background.
Eng ZH; Abdullah MI; Ng KL; Abdul Aziz A; Arba'ie NH; Mat Rashid N; Mat Junit S
Front Endocrinol (Lausanne); 2022; 13():1039494. PubMed ID: 36686473
[TBL] [Abstract][Full Text] [Related]
2. A mutation panel comprising BRAF
Eng ZH; Ahmad Jefry MM; Ng KL; Abdul Aziz A; Mat Junit S
Malays J Pathol; 2023 Dec; 45(3):375-390. PubMed ID: 38155379
[TBL] [Abstract][Full Text] [Related]
3. Changes in antioxidant status and DNA repair capacity are corroborated with molecular alterations in malignant thyroid tissue of patients with papillary thyroid cancer.
Eng ZH; Abdul Aziz A; Ng KL; Mat Junit S
Front Mol Biosci; 2023; 10():1237548. PubMed ID: 37692064
[No Abstract] [Full Text] [Related]
4. The Profile of Genetic Mutations in Papillary Thyroid Cancer Detected by Whole Exome Sequencing.
Fang Y; Ma X; Zeng J; Jin Y; Hu Y; Wang J; Liu R; Cao C
Cell Physiol Biochem; 2018; 50(1):169-178. PubMed ID: 30278442
[TBL] [Abstract][Full Text] [Related]
5. Tissue and serum samples of patients with papillary thyroid cancer with and without benign background demonstrate different altered expression of proteins.
Abdullah MI; Lee CC; Mat Junit S; Ng KL; Hashim OH
PeerJ; 2016; 4():e2450. PubMed ID: 27672505
[TBL] [Abstract][Full Text] [Related]
6. Novel somatic alterations underlie Chinese papillary thyroid carcinoma.
Yang C; Xu W; Gong J; Liu Z; Cui D
Cancer Biomark; 2020; 27(4):445-460. PubMed ID: 32065787
[TBL] [Abstract][Full Text] [Related]
7. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Recurrent LMO7-BRAF Fusion in Papillary Thyroid Carcinoma.
He H; Li W; Yan P; Bundschuh R; Killian JA; Labanowska J; Brock P; Shen R; Heerema NA; de la Chapelle A
Thyroid; 2018 Jun; 28(6):748-754. PubMed ID: 29768105
[TBL] [Abstract][Full Text] [Related]
9. High Prevalence of Gene Fusions and Copy Number Alterations in Pediatric Radiation Therapy-Induced Papillary and Follicular Thyroid Carcinomas.
Hess JR; Newbern DK; Beebe KL; Walsh AM; Schafernak KT
Thyroid; 2022 Apr; 32(4):411-420. PubMed ID: 34915766
[No Abstract] [Full Text] [Related]
10. iTRAQ analysis of urinary proteins: Potential use of gelsolin and osteopontin to distinguish benign thyroid goiter from papillary thyroid carcinoma.
Jayapalan JJ; Lee CS; Lee CC; Ng KL; Junit SM; Hashim OH
Clin Biochem; 2018 Mar; 53():127-131. PubMed ID: 29355489
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
[TBL] [Abstract][Full Text] [Related]
12. Relationship between genetic alterations and clinicopathological characteristics of papillary thyroid carcinoma.
Kure S; Wada R; Naito Z
Med Mol Morphol; 2019 Dec; 52(4):181-186. PubMed ID: 30788603
[TBL] [Abstract][Full Text] [Related]
13. Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome Sequencing Identifies a Novel Hedgehog-Interacting Protein G516R Mutation in Locally Advanced Papillary Thyroid Cancer.
Lee WK; Lee SG; Yim SH; Kim D; Kim H; Jeong S; Jung SG; Jo YS; Lee J
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30241415
[TBL] [Abstract][Full Text] [Related]
15. Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma.
Rubinstein JC; Brown TC; Christison-Lagay ER; Zhang Y; Kunstman JW; Juhlin CC; Nelson-Williams C; Goh G; Quinn CE; Callender GG; Udelsman R; Lifton RP; Korah R; Carling T
BMC Cancer; 2016 Aug; 16():646. PubMed ID: 27538953
[TBL] [Abstract][Full Text] [Related]
16. Identification of Specific Long Non-Coding RNA Expression: Profile and Analysis of Association with Clinicopathologic Characteristics and BRAF Mutation in Papillary Thyroid Cancer.
Wang Q; Yang H; Wu L; Yao J; Meng X; Jiang H; Xiao C; Wu F
Thyroid; 2016 Dec; 26(12):1719-1732. PubMed ID: 27758138
[TBL] [Abstract][Full Text] [Related]
17. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.
Zhang C; Bo C; Guo L; Yu P; Miao S; Gu X
World J Surg Oncol; 2019 Dec; 17(1):221. PubMed ID: 31842912
[TBL] [Abstract][Full Text] [Related]
18. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
19. Identification of biomarkers associated with cervical lymph node metastasis in papillary thyroid carcinoma: Evidence from an integrated bioinformatic analysis.
Zhang Z; Zhao S; Wang K; Shang M; Chen Z; Yang H; Chen Y; Chen B
Clin Hemorheol Microcirc; 2021; 78(2):117-126. PubMed ID: 33554894
[TBL] [Abstract][Full Text] [Related]
20. Different Molecular Phenotypes of Progression in BRAF- and RAS-Like Papillary Thyroid Carcinoma.
Lim J; Lee HS; Park J; Kim KS; Kim SK; Cho YW; Song YS
Endocrinol Metab (Seoul); 2023 Aug; 38(4):445-454. PubMed ID: 37461149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
